Exploring Psychedelic Policy & Advocacy in Canada

You’re invited to join our Executive Director, Scott Bernstein, for an exclusive online discussion on current Canadian psychedelic policy; recent changes to Health Canada’s Special Access Program; and the importance of MAPS Canada’s advocacy work in changing psychedelic policy.

This session will also provide a sneak peek of our upcoming webinar series on Canadian Psychedelic Policy & Advocacy, as well as the opportunity to ask Scott any questions you may have. We hope you’ll join us!



Scott Bernstein

Scott is the Executive Director of MAPS Canada. Scott previously served as Director of Policy for the Canadian Drug Policy Coalition, where he led the organization’s work on legal regulation of drugs, decriminalization and safe supply. Originally from the US, Scott came to Vancouver in 2006 to study law.